Q4 2023 13F Holders as of 31 Dec 2023
-
Type / Class
-
Equity / COM NEW
-
Number of holders
-
9
-
Total 13F shares, excl. options
-
78,706
-
Shares change
-
-17,301
-
Total reported value, excl. options
-
$113,335
-
Value change
-
-$26,906
-
Number of buys
-
5
-
Number of sells
-
2
-
Price
-
$1.44
Institutional Holders of Hoth Therapeutics, Inc. - COM NEW (HOTH) as of Q4 2023
As of 31 Dec 2023 Hoth Therapeutics, Inc. - COM NEW (HOTH) had 9 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions held a total of 78,706 shares of stock of the company.
Largest 9 holders included VANGUARD GROUP INC, GEODE CAPITAL MANAGEMENT, LLC, UBS Group AG, JPMORGAN CHASE & CO, Tower Research Capital LLC (TRC), WELLS FARGO & COMPANY/MN, McGlone Suttner Wealth Management, Inc., MORGAN STANLEY, and OSAIC HOLDINGS, INC..
This table shows 9 institutional shareholders of the security as of 31 Dec 2023.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.